Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Long-Term Debt Repayments (2016 - 2018)

Lisata Therapeutics' Long-Term Debt Repayments history spans 9 years, with the latest figure at $23000.0 for Q3 2018.

  • For Q3 2018, Long-Term Debt Repayments fell 99.55% year-over-year to $23000.0; the TTM value through Jun 2019 reached $23000.0, down 96.03%, while the annual FY2018 figure was $159000.0, 83.52% down from the prior year.
  • Long-Term Debt Repayments reached $23000.0 in Q3 2018 per LSTA's latest filing, down from $69000.0 in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $8.6 million in Q4 2016 to a low of -$5.6 million in Q3 2016.
  • Average Long-Term Debt Repayments over 5 years is $736704.3, with a median of $280133.0 recorded in 2014.
  • The largest YoY upside for Long-Term Debt Repayments was 16980.58% in 2016 against a maximum downside of 723.27% in 2016.
  • A 5-year view of Long-Term Debt Repayments shows it stood at $359668.0 in 2014, then plummeted by 85.95% to $50543.0 in 2015, then surged by 16980.58% to $8.6 million in 2016, then plummeted by 154.28% to -$4.7 million in 2017, then soared by 100.49% to $23000.0 in 2018.
  • Per Business Quant, the three most recent readings for LSTA's Long-Term Debt Repayments are $23000.0 (Q3 2018), $69000.0 (Q2 2018), and $67000.0 (Q1 2018).